Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001) - Druce, M R; Kaltsas, G A; Fraenkel, M; Gross, D J; Grossman, A B (Horm Metab Res, 2009)